胰腺癌的中医药治疗研究进展

Research progress of TCM therapy for pancreatic cancer

胰腺癌是一种常见的消化系统恶性肿瘤,具有恶性程度高、治疗预后差的特点。目前,全世界胰腺癌的发病率及死亡率呈逐年上升趋势。中国癌症中心最新统计数据表明,胰腺癌的发病率已上升至第9位,死亡率为第6位[1],5年生存率仅仅为7.2%[2]。现代研究表明,胰腺癌的发病与吸烟、饮酒、饮食结构失衡、肥胖等诸多不良生活习惯有关,同时,家族遗传、慢性炎症、肠道菌群失调亦是胰腺癌发病的危险因素[3]。

At present, the incidence of pancreatic cancer is increasing year by year, and China is no exception, with its insidious onset and poor prognosis. Although modern medicine has explored the pathogenesis of pancreatic cancer from the aspects of histomorphology, molecular genetics and tumor biology, the treatment of pancreatic cancer has made continuous progress from chemoradiotherapy to targeted immunotherapy. However, how to improve the quality of life and prolong the survival of patients still remains a hot spot of research and a difficult task for clinical workers to overcome relentlessly. TCM is one of the main means to treat pancreatic cancer. Based on the previous achievements, reviewed the basic and clinical research of TCM and combined traditional Chinese and Western Medicine in the treatment of pancreatic cancer. The results show that TCM plays an important role in the occurrence and development of pancreatic cancer, and has advantages in improving clinical symptoms, clinical efficacy, the quality of life and prolonging survival.